MIBG/I-123 (solution for injection)

MI-23

Indications

  • Diagnostic scintigraphic localisation of tumours originating in tissue that embryologically stems from the neural crest. These are pheochromocytomas, paragangliomas, chemodectomas and ganglioneuromas.
  • Detection, staging and follow-up on therapy of neuroblastomas.
  • Evaluation of the uptake of iobenguane. The sensitivity to diagnostic visualisation is different for the listed pathologic entities. Pheochromocytomas and neuroblastomas are sensitive in approx. 90% of patients, carcinoids in 70% and MCT in only 35%.
  • Functional studies of the adrenal medulla (hyperplasia) and the myocardium (sympathetic innervation).

Shelf life
30 h after the hour and date of manufacturing (expiry date is given on the packaging)

Shelf-life and storage conditions after radiolabelling

  • at temperature below 25ºC (protect from light)
Please note that this product does not have a Marketing Authorization (MA) in NL/BE/LUX.